EANM Marie Curie Award

Who can apply?

  • Candidates must have their regular residence in Europe.
  • At least one of the authors must be a member of the EANM.
  • Only workwhich has been done in Europe can be considered.
  • The submitted paper must not have been published before the last EANM Congress; possible candidates are invited by the Congress Chair to provide testimony for this.
  • A certificate must be presented, showing that legal requirements (including ethical and radiation protection requirements) were met when performing the study.
  • The Award should be given to the author of the work which is, in terms of scientific quality, the best contribution at the annual EANM Congress.


The Award:

  • Presentation of the research during the Congress.
  • Marie Curie Medal and diploma awarded by the EANM President.
  • Award of € 5,000.-, will be transferred after the Congress.
  • One complimentary (non-transferable) registration for either the next year’s annual congress or the upcoming Focus Meeting.


Application and Procedure:

  • The best scored 2 abstracts (after review process (blinded)) from each abstract category fulfilling the MCA criteria are selected. In addition to that, the 10 best scored abstracts (out of all submissions) will be added – if not already among the chosen ones.
  • Those abstracts will be again blinded and rated by the EANM Scientific Programme Council.
  • The best 10 rated abstracts will be once more reviewed (again blinded) by international peer reviewers*.
    *The EANM Board will suggest at least 10 peer reviewers who are neither linked to any of the abstracts, mentioned authors nor the institutions involved. 
  • The EANM office will notify the authors of the top 3 submissions, requesting a portrait picture, a 2-slides-presentation and their onsite presence at the Hand Over Session.
  • The Award is bestowed during the EANM Congress by the EANM President. The decision is not open to appeal or legal action.
  • NB: The EANM Board is not involved in any selection process at any time, and all scores will be given during the three rating stages to anonymized abstracts. 



For outstanding scientific work presented at the 34th Annual Congress of the European Association of Nuclear Medicine the Marie Curie Fund of the EANM bestowed the Marie Curie Award to

E. Pauwels1, F. Cleeren2, T. Tshibangu2, M. Koole1, K. Serdons1, L. Boeckxstaens1, J. Dekervel3, T. Vandamme4,5, W. Lybaert5, B. Van den Broeck6, P. M. Clement7, K. Geboes8, E. Van Cutsem3, S. Stroobants9, C. Verslype3, G. Bormans2, C. M. Deroose1;

1Nuclear Medicine, University Hospitals Leuven; Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, BELGIUM, 2Radiopharmaceutical Research, Department of Pharmacy and Pharmacology, KU Leuven, Leuven, BELGIUM, 3Digestive Oncology, University Hospitals Leuven, Leuven, BELGIUM, 4Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, BELGIUM, 5Oncology, NETwerk Antwerpen-Waasland CoE, Antwerpen, BELGIUM, 6Nuclear Medicine, Ghent University Hospital, Ghent, BELGIUM, 7General Medical Oncology, University Hospitals Leuven, Leuven, BELGIUM, 8Digestive Oncology, Department of Gastroenterology, Ghent University Hospital, Ghent, BELGIUM, 9Nuclear Medicine, Antwerp University Hospital; Molecular Imaging and radiology, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, BELGIUM.

for the abstract:

“[18F]AlF-NOTA-octreotide vs. [68Ga]Ga-DOTA-somatostatin analogue PET in neuroendocrine tumour patients: final results of a prospective multicentre trial”